Bath & Body Works (WBO:LBRA) Notes Receivable: €0 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:LBRA Bath & Body Works Inc WBO:LBRA
61 GF Score
Price €17.47
GF Value €29.17
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Bath & Body Works Notes Receivable?

Bath & Body Works WBO:LBRA -3.72% 61 Notes Receivable is €0 Mil as of Apr. 2026. GuruFocus rates WBO:LBRA with a GF Score™ of 61/100 and a GF Value™ of €29.17 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Bath & Body Works's Notes Receivable for the quarter that ended in Apr. 2026 was €0 Mil.

Bath & Body Works Notes Receivable Related Terms

Bath & Body Works Notes Receivable Historical Data

* Premium members only.

The historical data trend for Bath & Body Works's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bath & Body Works Notes Receivable Chart

Bath & Body Works Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bath & Body Works Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WBO:LBRA
61GF Score
Bath & Body Works Inc WBO:LBRA
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bath & Body Works Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of €0 Mil mean?
Bath & Body Works (WBO:LBRA) has a Notes Receivable of €0 Mil as of Apr. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Bath & Body Works and its competitors.
Is Bath & Body Works' Notes Receivable too high?
Bath & Body Works' current Notes Receivable is €0 Mil. Overall, Bath & Body Works has a GF Score™ of 61/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bath & Body Works' Notes Receivable compare to MNSO and RH?
Bath & Body Works' Notes Receivable of €0 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Retail - Cyclical company?
A good Notes Receivable depends on the Retail - Cyclical industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Bath & Body Works and its competitors. Bath & Body Works's current Notes Receivable is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bath & Body Works stock overvalued right now?
Based on GuruFocus' analysis, Bath & Body Works (WBO:LBRA) is currently considered Significantly Undervalued. The stock's GF Value™ is €29.17, compared to a current price of €17.47 — trading 40.1% below its estimated fair value. The current Notes Receivable is €0 Mil. Bath & Body Works' overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Bath & Body Works (WBO:LBRA), the current Notes Receivable is €0 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bath & Body Works (WBO:LBRA) Overvalued in 2026?

Based on GuruFocus' analysis, Bath & Body Works stock appears to be undervalued. The current stock price of €17.47 is trading 40.1% below its estimated GF Value™ of €29.17. GuruFocus considers Bath & Body Works to be Significantly Undervalued.

Key valuation signals for WBO:LBRA:

  • Notes Receivable: €0 Mil
  • GF Value™: €29.17 vs. price of €17.47 (40.1% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the WBO:LBRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bath & Body Works Business Description

Address Three Limited Parkway, Columbus, OH, USA, 43230
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 4% of sales from international markets in fiscal 2025. For fiscal 2025, 77% of sales stemmed from the brick-and-mortar network of more than 1,900 retail stores, similar to 2024 levels, as consumer shopping patterns remained normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like men's and lip.
61GF Score

Get the complete analysis for WBO:LBRA

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.47
Price
€29.17
GF Value